|
GlaxoSmithKline signs multi-part deal with rival Novartis 22-04-14 10:12 AM GlaxoSmithKline has agreed to sell its oncology portfolio to Novartis, while Novartis will sell its vaccines business for an initial $5.25billion (£3.1billion) to Glaxo. Source... |
| الساعة الآن 06:43 AM |
Powered by vBulletin® Copyright ©2000 - 2026, Jelsoft Enterprises Ltd.
Content Relevant URLs by vBSEO 3.5.2 TranZ By
Almuhajir